Ligand id: 6962
Name: roflumilast
View more information in the IUPHAR Pharmacology Education Project: roflumilast
|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2011)) |
IUPAC Name ![]() |
3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE |
International Nonproprietary Names ![]() |
|
INN number | INN |
7598 | roflumilast |
Synonyms ![]() |
BY-217 | BYK-20869 | Daliresp® | Daxas® |
Database Links ![]() |
|
CAS Registry No. | 162401-32-3 |
ChEMBL Ligand | CHEMBL193240 |
DrugBank Ligand | DB01656 |
GtoPdb PubChem SID | 178103543 |
PubChem CID | 449193 |
RCSB PDB Ligand | ROF |
Search Google for chemical match using the InChIKey | MNDBXUUTURYVHR-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | MNDBXUUTURYVHR |
Search PubMed clinical trials | roflumilast |
Search PubMed titles | roflumilast |
Search PubMed titles/abstracts | roflumilast |
Search UniChem for chemical match using the InChIKey | MNDBXUUTURYVHR-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | MNDBXUUTURYVHR |
SynPHARM | 79214 (in complex with phosphodiesterase 4B) |
Wikipedia | Roflumilast |
Comments |
Roflumilast is a phosphodiesterase-4 inhibitor. |